Structure Solved by Scientists at TSRI Marks Important Milestone in Effort to Develop HIV Vaccine
Scientists working at The Scripps Research Institute (TSRI) and the Glycobiology Institute at Oxford University in the United Kingdom have published the structure of an antibody that effectively neutralizes human immunodeficiency virus (HIV). The authors hope that this structure will provide a basis for the design of effective vaccines against the HIV virus.

Generous Gifts Make Possible the First Norton B. Gilula Fellowships and 11 Other Merit Awards for TSRI Graduate Students
Thirteen graduate students will receive 2001-2002 merit-based awards, which include the first Norton B. Gilula Fellowships.

TSRI Investigator Receives Leukemia and Lymphoma Society Award
Associate Professor Wendy Havran is being awarded the Stohlman Scholar Award from the Leukemia and Lymphoma Society.

Snapshot: Matt Barnas
Meet Senior Systems Analyst Matt Barnas, a.k.a. "one of the Mac guys."


Turning Off Pain's Pathways

TSRI investigator Ben Cravatt's research on the fatty acid amide hydrolase (FAAH) holds out promise for suggesting a way to alleviate pain with few side effects.